Search

Evaluates the possibility of finding previously unidentified carriers of the genetic defect fragile X syndrome. Use of carriers in antenatal diagnosis; Analysis of family attitude towards genetic screening.

We compared the efficacy of maternal serum testing and fetal nuchal translucency measurements, both combined and individually, as first-trimester screening methods for Down syndrome. [ABSTRACT FROM PUBLISHER]